Live Varicella Vaccine : Prevention of Nosocomial Infection and Protection of High Risk Infants from Varicella Infection by Sugino, Hirotoshi et al.
Title
Live Varicella Vaccine : Prevention of
Nosocomial Infection and Protection of High Risk
Infants from Varicella Infection
Author(s)
Sugino, Hirotoshi; Tsukino, Ryuichi; Miyashiro,
Eikichi; Dezawa, Tohru; Shinohara, Kunikazu;
Uemura, Shigeru; Koike, Michio







Osaka University Knowledge Archive : OUKA
https://ir.library.osaka-u.ac.jp/
Osaka University
Ll\IE VARICELLA VACCINE: PREVENTION OF NOSOCOMIAL
INFECTION AND PROTECTION OF HIGH RISK INFANTS
FRO^, I VARICELLA INFECTION
HiROTosHi SUGTNo, RYuicHi TsuKiNo,
ETKiCHI MIYASHIRO, ToHRU DEZA\\;A,
KUNIKAZU SHINOHARA, SHIGERU UEl\IURA
and AllCH10 1<01KE
Department of Pediatrics, \\, akayama Medical College, 7 ban-clto, \\!akayama, 640 Japait
For prevention of nosocomial infection, 25 infants including high risk atlents
received an emergenq, injection of live vancella vaccine. Three patients develo ed
a rash within 5 days after vaccination, but their symptoms were mild. The other
22 showed no clinical symptoms and gave an immune response.
Twenty-two patients receiving jinmunosuppressive therapy were vaccinated and
20 of them showed a positive response in the \, an cella skin test. Of 14 vaccinated
patients with malignancies, 2 giving a positive skin test, later showed clinical
varicella, but their symptoms were not severe. One case with ALL was jinmu-
nized safely tinder very poor conditions dtiring the first induction thera , No
complications were observed in any patients.
BIKEN JOURNAL V01.27.63-65, 1984
INTRODUCTION
Vancella-zoster virus is very infectious, and
infection of jinmunocompromiscd patients
causes severe symptoms with a high mortality
A live \, an cella vaccine developed byrate
Tat"hachi (Tat^hachi at a1. , 1974) ha^ hern
used safely and effective Iy for such infants in
man^ hospitals (Ha at a1. , 1980; 1<atsushima
at a1. , 1982). In this report we describe our
experience in the use of this vaccine for pro-
tection against nosocomial infections (emer-
genq, vaccination) and also for protection of
high risk infants from infection with vai. icella
MATERIALS AND METHODS
Live vancella vaccine (Oka strain) and skin test solu-
tion (Kamiya at all. , 1977) were supplied by Professor
Takahashi. Vticcine \\. as injected subcutaneously
at doses 375 to 1,000 (usually 500) PIaque-forming
units per person
During 5 outbreaks of \, aricella between A'lay '79
and June '81,25 hospitalized children witlT no past
history of varicella \\, ho gave a negati\, e \, an cella skin
test were selected as subjects for emergency, vaccina-
TITey. were \, accinatcd \\. ith the consent oftlOIT
their parents
Titc I, Igl\ risk group of 22 \, accinees consisted of
14 \\, ith nTalignai, cies re ALL (acute lymphocytic
Ieul{emia), 2 AML (acute myelocytic leukemia), I
yoll< sack tumor, I embryonal carcinoma, I neuro-
blastomnl, 6 \\, itit the nephrotic syndrome etc. and
2 witlT the \\, est s}. ridrome. Of these, 5 children
received emergency \, arccination at the time of an
outbreak of \, aricelIa. All of them had been re-
63
ceiving anticancer or Immunosuppressive tlTerapy.
RESULTS AND DISCUSSION
I. ,,, rerge"cy uricci, ,"ti'off (Table I)
The first case of vancella occurred in late
MarclT '79, and 4 other cases occurred within
the next 30 days. Vancella vaccination was
started on May I.
At that time, 35 infants were hospitalized
in our pediatric ward : there were 2 varicella
patients, 9 patients with a past history of vari-
cella, and 24 susceptible patients. Among
these susceptible patients, 9 received vaccina-
tion and 8 did not. The other 7 patients were
TABLE I. lithihitzb?I of nosocomial infect, 'o72
by warice//a macci?intro"
discharged from hospital.
Two of the 9 patients who received vaccina-
tion developed a rash, but their symptoms
were mild. Among the 8 patients who did not
receive vaccination, 4 patients developed van-
cella, one case developing after 20 days. The
remaining 4 patients were 3 newborn babies,
one being in an incubator.
In the first episode, 11 patients were vac-
cinated, including 2 who were hospitalized
after the beginning of vaccination.
Subsequently, there were 4 outbreaks of
vancella in our ward and, in all, 25 patients
were vaccinated. Three of these developed a
rash 2.4 and 5 days, respectively, after vac-
cination, but their symptoms were mild. Prob-
ably they were in the latent period at the time
of vaccination. in the other 22 patients who
were jinmunized, the vaccine was effective.
2. Pacci?Iati'o11 of hig/I risk childi'e?I (Table 2)
Twelve of the 14 children with malignancies
who were vaccinated showed a positive re-
sponse in the skin test, but 2 of them de-
veloped clinical vancella H and 21 months
after vaccination. Two children with A1\{L
did not give a positive response in the skin
test although they received vaccination during
























































it One case received 2.5 g of immunoglobulin on day 2, and developed \, aricella on day, 27. Another one





























in unoglobulin on day 2 after \, accination ; the
skin test on day, 17 was negative, and on the
day 27 vancella developed. The other child
whose skin test was negative on days 21 and
84, received a second vaccination 3 months
after the first \, arccination. After this the skin
test was positive.
All 8 children with the nephrotic syndrome
and the west syndrome were vaccinated with-
out complication and gave positive reactions
in the skin test.
it is noteworthy that vancella developed in
a few children with malignancies even tlTough
they gave positive reactions in the skin test at
one time. For example, a 4-year-old boy with
ALL was \, accinated during remission 18
months after the onset of illness because his
father suffered from herpes-zoster. In spite
of the fact that he gave a positive reaction in
the skin test 15 days after vaccination, Ile de-
velopcd varicella after 11 months, but the
symptoms were mild. He also gave a positive
reaction in the skin test 3 days before the ap-
pearance of a rash. A second case of ALL, a
7-year-old boy, was vaccinated one month
after the onset of ALL. He gave a positive
reaction in the skin test on days 17 and 25.
After that, Ile suffered relapses and remissions
of ALL. After 21 month he developed vari-
cella, possibly due to a long period of anti-
cancer therapy.
3. fineige"cy 21acc!"dti'o11 of d case I'?I tie, JJ pool'
clinical coJidrt!bii
Children, especially thosc with leukemia,
should be vaccinated under good conditions
(Izawa at a1. , 1977), but occasionally even when
the clinical condition is bad, emergency, vac-
cination is necessa^, (Ozaki at a1. , 1978 ; Naka-
gawa and 1< atsushima, 1978).
A 3~year-old boy with newly developed ALL
was admitted to our hospital during an epi-
demic of vancella. A skin test for vancella
and a test for serum antibody both gave nega~
tive results. A few days after 11is admission,
varicclla developed in children in the adjacent
His parents requested emergency \, ac-
cination. Therefore, he received vaccination
under very poor Immunological conditions dur-
ing the first induction therapy. He had re-
CGIved vincristin 7 days previously and Ieu-
kocytes in ITis peripheral blood had decreased
to 1300jmm' at the time of vaccination. On
day 4 after vaccination he received 2.5 g of
immunoglobulin. He showed complete reinis-
SIon and did not catch vancella. NIOreover,
he gave positive reaction in the skin test on
days 18 and 46 after vaccination.
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